QQ客服 官方微博 反馈留言

	The combined treatment of amyloid-beta(1-42)-stimulated bone marrow-derived dendritic cells plus splenocytes from young mice prevents the development of Alzheimer's disease in APPswe/PSENldE9 mice
	Wang, Fei; Liu, Hanqiu; Shen, Xueyan; Ao, Hong; Moore, Nick; Gao, Lingling; Chen, Long; Hua, Heng; Maa, Huiying; Yang, Zixiao
刊名	NEUROBIOLOGY OF AGING
	2015
卷号	36期号:1
关键词	Alzheimer's disease Bone marrow derived dendritic cell Immunotherapy Immune senescence
ISSN号	0197-4580
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4871270
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Wang, Fei,Liu, Hanqiu,Shen, Xueyan,et al. The combined treatment of amyloid-beta(1-42)-stimulated bone marrow-derived dendritic cells plus splenocytes from young mice prevents the development of Alzheimer's disease in APPswe/PSENldE9 mice[J]. NEUROBIOLOGY OF AGING,2015,36(1).
APA	Wang, Fei.,Liu, Hanqiu.,Shen, Xueyan.,Ao, Hong.,Moore, Nick.,...&Liang, Chunmin.(2015).The combined treatment of amyloid-beta(1-42)-stimulated bone marrow-derived dendritic cells plus splenocytes from young mice prevents the development of Alzheimer's disease in APPswe/PSENldE9 mice.NEUROBIOLOGY OF AGING,36(1).
MLA	Wang, Fei,et al."The combined treatment of amyloid-beta(1-42)-stimulated bone marrow-derived dendritic cells plus splenocytes from young mice prevents the development of Alzheimer's disease in APPswe/PSENldE9 mice".NEUROBIOLOGY OF AGING 36.1(2015).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。